Non-ischemic Cardiomyopathy Clinical Trial
Official title:
Phase II Study of Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy
Non-ischemic cardiomyopathy and heart failure are highly influenced by the presence of
systemic inflammation.
Doxycycline is a FDA-approved drug to treat bacterial infections which also shows powerful
anti-inflammatory effects.
In this study we plan to determine the effects of Doxycycline in patients with stable heart
failure and non-ischemic cardiomyopathy on peak of aerobic exercise capacity (peak V02) and
ventilator efficiency measured with a cardiopulmonary test.
In this study of Safety and Efficacy of Doxycycline in Patients with Non-Ischemic Cardiomyopathy Population, we will enroll 24 patients with a clinical diagnosis of heart failure and non-ischemic cardiomyopathy (recent imaging study documenting LV ejection fraction <50%, and no history of coronary or ischemic heart disease) in a single-center, randomized, double-blinded, placebo-controlled clinical trial with allocation 1:1:1 to Doxycycline 100 mg twice daily or Doxycycline 20 mg twice daily or Placebo for 2 weeks. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Not yet recruiting |
NCT01447069 -
Use of Beta-agonists in Stable Severe Congestive Heart Failure
|
N/A | |
| Recruiting |
NCT05572957 -
LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB
|
N/A | |
| Enrolling by invitation |
NCT03293381 -
Electrogram-Guided Myocardial Advanced Phenotyping
|
||
| Recruiting |
NCT03830957 -
Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker
|
N/A | |
| Suspended |
NCT03071653 -
Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study
|
Phase 2 | |
| Terminated |
NCT03925324 -
Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device
|
Phase 2 | |
| Completed |
NCT02657967 -
Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyopathy
|
||
| Recruiting |
NCT05855135 -
Assessment of Combined CCM and ICD Device in HFrEF
|
N/A | |
| Completed |
NCT04325594 -
The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Non-ischemic Heart Failure
|
Phase 2 | |
| Active, not recruiting |
NCT01643330 -
A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
|
Phase 2 | |
| Completed |
NCT03509441 -
Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance
|
||
| Completed |
NCT04607265 -
Sudden Death Stratification
|
||
| Withdrawn |
NCT01787851 -
Study of the Acute Effects of Triheptanoin in Heart Failure
|
Phase 1/Phase 2 | |
| Terminated |
NCT01966887 -
AAV1-CMV-Serca2a GENe Therapy Trial in Heart Failure
|
Phase 2 | |
| Recruiting |
NCT06243653 -
Relationship Between Coronary Microvascular Dysfunction and Improvement of Left Ventricular Systolic Function in Patients With Heart Failure With Reduced Ejection Fraction Caused by Non-ischemic Etiology
|
||
| Recruiting |
NCT04265040 -
DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies
|
||
| Terminated |
NCT02346422 -
A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
|
Phase 1/Phase 2 |